Skip Navigation


Rheumatology Advance Access originally published online on June 27, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
42/12/1452    most recent
keg403v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruperto, N.
Right arrow Articles by Martini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruperto, N.
Right arrow Articles by Martini, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 1452-1459
© 2003 British Society for Rheumatology


Paper

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

Nicolino Ruperto1,a, Angelo Ravelli1,a, Kevin J. Murray2,a, Daniel J. Lovell3,b, Boel Andersson-Gare4,a, Brian M. Feldman5,b, Stella Garay6,a, Wietse Kuis7,a, Claudia Machado8,a, Lauren Pachman9,b, Anne-Marie Prieur10,a, Lisa G. Rider11,b, Earl Silverman5,b, Elena Tsitsami12,a, Pat Woo13,a, Edward H. Giannini3,b and Alberto Martini1,a for the Paediatric Rheumatology International Trials Organisation (PRINTO)a and the Pediatric Rheumatology Collaborative Study Group (PRCSG)b

1IRCCS G. Gaslini, Pediatria II, Genova, Italy, 2Princess Margaret Hospital for Children, Perth, Australia, 3Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, USA, 4Ryhov’s County Hospital, Department of Pediatrics, Jönköping, Sweden, 5Hospital for Sick Children, Rheumatology Department, Toronto, ON, Canada, 6Hospital Sor María Ludovica, Unidad de Reumatologia, Buenos Aires, Argentina, 7UMC Utrecht-Wilhelmina Kinderziekenhuis, Department of Pediatric Immunology and Rheumatology Utrecht, The Netherlands, 8Department of Paediatrics, Botucatu Medical School, São Paulo, Brazil, 9Children’s Memorial Hospital, Immunology/Rheumatology, Chicago, IL, USA, 10Hôpital Necker Enfants Malades, Unite’ d’Immunologie, Hématologie et Rhumatologie Pédiatrique, Paris, France, 11Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA, 12Department of Pediatrics, Aristotle University, Thessaloniki, Greece and 13Great Ormond Street Hospital for Sick Children, Rheumatology Department, London, UK.

Correspondence to: Nicolino Ruperto, Paediatric Rheumatology International Trials Organisation (PRINTO), IRCCS G. Gaslini, Pediatria II, Largo Gaslini, 5, 16147 Genova, Italy. E-mail: nicolaruperto{at}ospedale-gaslini.ge.it

Abstract

Objective. To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM).

Methods. Two questionnaire surveys were mailed to 267 physicians from 46 different countries asking each member to select and rank the response variables used when assessing clinical response in patients with JSLE or JDM. Next, 40 paediatric rheumatologists from 34 countries met and, using the nominal group technique, selected the domains to be included in the disease activity and damage core sets for JSLE and JDM.

Results. A total of 41 response variables for JSLE and 37 response variables for JDM were selected and ranked through the questionnaire surveys. In the consensus conference, domains selected for both JSLE and JDM activity or damage core sets included the physician and parent/patient subjective assessments and a global score tool. Domains specific for JSLE activity were the immunological tests and the kidney function parameters. Concerning JDM, functional ability and muscle strength assessments were indicated for both activity and damage core sets, whereas serum muscle enzymes were included only in the activity core set. A specific paediatric domain called ‘growth and development’ was introduced in the disease damage core set for both diseases and the evaluation of health-related quality of life was advised in order to capture the influence of the disease on the patient lifestyle.

Conclusions. We developed preliminary core sets of measures for disease activity and damage assessment in JSLE and JDM. The prospective validation of the core sets is in progress.

KEY WORDS: Consensus, Core set, Disease activity assessment, Disease damage assessment, Juvenile dermatomyositis, Juvenile systemic lupus erythematosus.

Notes

Additional PRINTO National Co-ordinatorsa

members of the PRCSGb

Additional PRINTO National Co-ordinatorsa and members of the PRCSGb who attended the consensus conference held in Pavia, Italy from March 31 to April 3, 2001: Sang Cheol Baea (Seoul, South Korea), Zsolt Balogha (Budapest, Hungary), Ruben Burgos-Vargasa (Mexico City, Mexico), Carmen De Cuntoa (Buenos Aires, Argentina), Jaime De Inocencioa (Madrid, Spain), Pavla Dolezalovaa (Prague, Czech Republic), Miroslav Harjaceka (Zagreb, Croatia), Philip Hashkesa (Safed, Israel), Michael Hofera (Lausanne, Switzerland), Visa Honkanena (Helsinki, Finland), Christian Huemera (Bregenz, Austria), Hans-Iko Huppertza (Bremen, Germany), Rik Joosa (Gent, Belgium), Florence Kanakoudia (Thessaloniki, Greece), Vibke Lillebya (Oslo, Norway), Jose Melo-Gomesa (Lisbon, Portugal), Dimitrina Mihaylovaa (Sofia, Bulgaria), Susan Nielsena (Copenhagen, Denmark), Irina Nikishinaa (Moscow, Russia), Huri Ozdogana (Istanbul, Turkey), Kharaman Pagavaa (Tbilisi, Georgia), Anne M. Reedb (Rochester, MN, USA), Robert Rennebohmb (Columbus, OH, USA), Anna Maria Romickaa (Warsaw, Poland), Madeleine Rooneya (Belfast, UK), Ingrida Rumbaa (Riga, Latvia), Gordana Susica (Belgrade, Yugoslavia), Richard Veselya (Kosice, Slovakia).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
H. I. BRUNNER, G. C. HIGGINS, K. WIERS, S. K. LAPIDUS, J. C. OLSON, K. ONEL, M. PUNARO, J. YING, M. S. KLEIN-GITELMAN, and M. SEID
Health-related Quality of Life and Its Relationship to Patient Disease Course in Childhood-onset Systemic Lupus Erythematosus
J Rheumatol, July 1, 2009; 36(7): 1536 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. O. Harris-Love, J. A. Shrader, D. Koziol, N. Pahlajani, M. Jain, M. Smith, H. L. Cintas, C. L. McGarvey, L. James-Newton, A. Pokrovnichka, et al.
Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis
Rheumatology, February 1, 2009; 48(2): 134 - 139.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. M Ward
Interpreting measurements of physical function in clinical trials
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii32 - iii34.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. M. Huber, E. M. Dugan, P. A. Lachenbruch, B. M. Feldman, M. D. Perez, L. S. Zemel, C. B. Lindsley, R. M. Rennebohm, C. A. Wallace, M. H. Passo, et al.
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy
Rheumatology, October 1, 2007; 46(10): 1606 - 1611.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
L.T. Hiraki, J. Hamilton, and E.D. Silverman
Review: Measuring permanent damage in pediatric systemic lupus erythematosus
Lupus, August 1, 2007; 16(8): 657 - 662.
[Abstract] [PDF]


Home page
LupusHome page
L. Moorthy, M. Peterson, M. Harrison, K. Onel, and T. Lehman
Review: Quality of life in children with systemic lupus erythematosus: a review
Lupus, August 1, 2007; 16(8): 663 - 669.
[Abstract] [PDF]


Home page
LupusHome page
N. Ruperto, A. Bazso, A. Ravelli, C. Malattia, G. Filocamo, A. Pistorio, A.L. Rodriguez Lozano, S. Viola, and A. Martini
Review: The Paediatric Rheumatology International Trials Organization (PRINTO)
Lupus, August 1, 2007; 16(8): 670 - 676.
[Abstract] [PDF]


Home page
J Child NeurolHome page
C. H. Wang, R. S. Finkel, E. S. Bertini, M. Schroth, A. Simonds, B. Wong, A. Aloysius, L. Morrison, M. Main, T. O. Crawford, et al.
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
J Child Neurol, August 1, 2007; 22(8): 1027 - 1049.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
L. R. Wedderburn, P. Woo, and R. G. Hull
Paediatric rheumatology: a bright future in the UK and Europe
Rheumatology, April 1, 2005; 44(4): 423 - 425.
[Full Text] [PDF]


Home page
LupusHome page
F Perfumo and A Martini
Lupus nephritis in children
Lupus, January 1, 2005; 14(1): 83 - 88.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.